Immunome Reports First Quarter 2023 Financial Results : vima

Immunome, Inc. , a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported... | May 5, 2023

Related Keywords

London , City Of , United Kingdom , United States , Anthony Tolcher , Purnanand Sarma , John Lambert , Matthew Robinson , Drug Administration , Exchange Commission , Nasdaq , Immunome Inc , Twitter , Linkedin , Discovery Engine , Antibody Drug Conjugate , Immunome Announced Strategic Collaboration , Discover Multiple Novel Oncology , Announced Formation , Annual World , Chief Technology Officer , Collaboration Revenue , Collaboration Agreement , Private Securities Litigation Reform Act , Annual Report , United States Securities , Months Ended March , Simmunome , Nc Stock Exchange , News , Information , Press Release , Iopharmaceutical , Company , Hat , Utilizes , Its , Human , Memory , , Fell , Platform , O , Discover , End , Evelop , Ntibody , Herapeutics , Mprove , Patient , Oday Imnm Us45257u1088 ,